Fluoxetine hydrochloride

TargetMol
Product Code: TAR-T0450L
Supplier: TargetMol
CodeSizePrice
TAR-T0450L-25mg25mg£109.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0450L-1mL1 mL * 10 mM (in DMSO)£121.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0450L-50mg50mg£122.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0450L-100mg100mg£136.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0450L-200mg200mg£189.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0450L-500mg500mg£273.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Fluoxetine is the first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
CAS:
56296-78-7
Formula:
C17H18F3NO?HCl
Molecular Weight:
345.79
Pathway:
GPCR/G Protein; Neuroscience; Autophagy
Purity:
0.9966
SMILES:
Cl.CNCCC(Oc1ccc(cc1)C(F)(F)F)c1ccccc1
Target:
5-HT Receptor; Serotonin Transporter; Autophagy

References

1. Malberg JE, et al. Neuropsychopharmacology, 2003, 28(9), 1562-1571. 2. Kodama M, et al. Biol Psychiatry, 2004, 56(8), 570-580. 3. Wang JW, et al. J Neurosci, 2008, 28(6), 1374-1384. 4. Bymaster FP, et al. Psychopharmacology (Berl), 2002, 160(4), 353-361. 5. Zhang W, et al. Neuropsychopharmacology, 2000, 23(3), 250-262. 6. Su WJ, et al. Antidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance. J Neuroinflammation. 2017 Oct 30;14(1):210. 7. Gao T T, Wang Y, Liu L, et al. LIMK1/2 in the mPFC plays a role in chronic stress-induced depressive-like effects in mice[J]. International Journal of Neuropsychopharmacology. 2020, 23(12): 821-836.